238 related articles for article (PubMed ID: 29895432)
1. Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis.
Zhen Y; Lee IJ; Finkelman FD; Shao WH
J Autoimmun; 2018 Sep; 93():37-44. PubMed ID: 29895432
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S
Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499
[TBL] [Abstract][Full Text] [Related]
3. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
4. The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.
Hector A; Montgomery EA; Karikari C; Canto M; Dunbar KB; Wang JS; Feldmann G; Hong SM; Haffner MC; Meeker AK; Holland SJ; Yu J; Heckrodt TJ; Zhang J; Ding P; Goff D; Singh R; Roa JC; Marimuthu A; Riggins GJ; Eshleman JR; Nelkin BD; Pandey A; Maitra A
Cancer Biol Ther; 2010 Nov; 10(10):1009-18. PubMed ID: 20818175
[TBL] [Abstract][Full Text] [Related]
5. Glycoxidised LDL induced the upregulation of Axl receptor tyrosine kinase and its ligand in mouse mesangial cells.
Kim YS; Jung DH; Sohn E; Kim J; Kim JS
PLoS One; 2012; 7(11):e50297. PubMed ID: 23226259
[TBL] [Abstract][Full Text] [Related]
6. Axl Inhibitor R428 Enhances TRAIL-Mediated Apoptosis Through Downregulation of c-FLIP and Survivin Expression in Renal Carcinoma.
Woo SM; Min KJ; Seo SU; Kim S; Kubatka P; Park JW; Kwon TK
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269715
[TBL] [Abstract][Full Text] [Related]
7. Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE.
Orme JJ; Du Y; Vanarsa K; Mayeux J; Li L; Mutwally A; Arriens C; Min S; Hutcheson J; Davis LS; Chong BF; Satterthwaite AB; Wu T; Mohan C
Clin Immunol; 2016 Aug; 169():58-68. PubMed ID: 27237127
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Gas6 augments Axl and facilitates immune restoration in an intracerebral hemorrhage mouse model.
Tong LS; Shao AW; Ou YB; Guo ZN; Manaenko A; Dixon BJ; Tang J; Lou M; Zhang JH
J Cereb Blood Flow Metab; 2017 Jun; 37(6):1971-1981. PubMed ID: 27389179
[TBL] [Abstract][Full Text] [Related]
9. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.
Holland SJ; Pan A; Franci C; Hu Y; Chang B; Li W; Duan M; Torneros A; Yu J; Heckrodt TJ; Zhang J; Ding P; Apatira A; Chua J; Brandt R; Pine P; Goff D; Singh R; Payan DG; Hitoshi Y
Cancer Res; 2010 Feb; 70(4):1544-54. PubMed ID: 20145120
[TBL] [Abstract][Full Text] [Related]
10. Axl regulated survival/proliferation network and its therapeutic intervention in mouse models of glomerulonephritis.
Zhen Y; Ren Y; Medvedovic M; Adams DE; Wang D; Shao WH
Arthritis Res Ther; 2022 Dec; 24(1):284. PubMed ID: 36578056
[TBL] [Abstract][Full Text] [Related]
11. The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.
Antony J; Tan TZ; Kelly Z; Low J; Choolani M; Recchi C; Gabra H; Thiery JP; Huang RY
Sci Signal; 2016 Oct; 9(448):ra97. PubMed ID: 27703030
[TBL] [Abstract][Full Text] [Related]
12. Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas.
Tsukita Y; Fujino N; Miyauchi E; Saito R; Fujishima F; Itakura K; Kyogoku Y; Okutomo K; Yamada M; Okazaki T; Sugiura H; Inoue A; Okada Y; Ichinose M
Mol Cancer; 2019 Feb; 18(1):24. PubMed ID: 30744655
[TBL] [Abstract][Full Text] [Related]
13. Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib.
Giles KM; Kalinowski FC; Candy PA; Epis MR; Zhang PM; Redfern AD; Stuart LM; Goodall GJ; Leedman PJ
Mol Cancer Ther; 2013 Nov; 12(11):2541-58. PubMed ID: 24026012
[TBL] [Abstract][Full Text] [Related]
14. Opposing Roles of Tyrosine Kinase Receptors Mer and Axl Determine Clinical Outcomes in Experimental Immune-Mediated Nephritis.
Zhen Y; Priest SO; Shao WH
J Immunol; 2016 Sep; 197(6):2187-94. PubMed ID: 27527599
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma.
Scherschinski L; Prem M; Kremenetskaia I; Tinhofer I; Vajkoczy P; Karbe AG; Onken JS
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055167
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma.
Hong J; Maacha S; Belkhiri A
Mol Oncol; 2018 Dec; 12(12):2191-2208. PubMed ID: 30353671
[TBL] [Abstract][Full Text] [Related]
17. AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction.
Landolt L; Furriol J; Babickova J; Ahmed L; Eikrem Ø; Skogstrand T; Scherer A; Suliman S; Leh S; Lorens JB; Gausdal G; Marti HP; Osman T
Physiol Rep; 2019 May; 7(10):e14091. PubMed ID: 31134766
[TBL] [Abstract][Full Text] [Related]
18. Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells.
Kurata A; Tachibana Y; Takahashi T; Horiba N
PLoS One; 2020; 15(4):e0232055. PubMed ID: 32324796
[TBL] [Abstract][Full Text] [Related]
19. AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.
Chen TJ; Mydel P; Benedyk-Machaczka M; Kamińska M; Kalucka U; Blø M; Furriol J; Gausdal G; Lorens J; Osman T; Marti HP
Physiol Rep; 2021 Dec; 9(23):e15140. PubMed ID: 34877810
[TBL] [Abstract][Full Text] [Related]
20. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis.
Yanagita M; Arai H; Ishii K; Nakano T; Ohashi K; Mizuno K; Varnum B; Fukatsu A; Doi T; Kita T
Am J Pathol; 2001 Apr; 158(4):1423-32. PubMed ID: 11290560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
